Technology Transfer

Posters

• Novel Methods for Inhibiting Angiogenesis
  
• MED1: A Novel Gene Associated with Cancer Drug Resistance
  
• Human BUB Genes (huBUB1A, huBUB1B, hBUBR1): Mitotic Checkpoint Kinases
  
• p53 Repression Elements in the Surviving and MAP4 Promoters
  
• OVCA1 and OVCA2 Tumor Suppressor Genes
  
• Tumor-specific Antisense Therapy to Inhibit Bcl-2 Expression and Induce Apoptosis for Treatment of Non-Hodgkin's Lymphoma
  
• Hef1/Cas-L, a Novel Signal Transduction Molecule Associated with Cell Motility, Growth, Apoptosis and Oncogenic Transformation
  
• Anti-HER2/neu-Anti-CHX-A Bispecific Single-Chain FV Molecules for Pretargeted Radioimmunotherapy and Detection of Cancer
  
• Anti-HER2/neu Anti-peptide Ligand Bispecific Single-Chain FV Molecules for Pretargeted Radioimmunotherapy and Detection of Cancer
  
• Anti-MISIIR (Anti-Mullerian Inhibiting Substance Type II Receptor) Antibody Immunoconjugates to Detect and Treat Ovarian Cancer)
  
• EFGR/NEDD9/TGF-B Interactome and Methods of Use for the Identification of Agents Useful to Treat Hyperproliferative Disorders
  
• Promoter Hypermethylation of the IGFBP1 Gene in Cancer
  
• Methylation of the MAL Gene in Cancer Cells
  
• Detection of Breast Cancer at a Stage Earlier than Detectable by Mammogram
  
• Inhibitors of Pak and a Method To Screen for Inhibitors of Pak
  
• Novel Methods for Inhibiting Angiogenesis
  
• ATR Kinase: A Novel Target for Anti-retroviral Drug Discovery
  
• HEF1: Nucleic Acid Encoding a Signal Mediator Protein that Induces Cellular Morphological Alterations"
  
• Therapeutic Effect of Imatinib in Gastrointestinal Stromal Tumors: AKT Signaling Dependent and Independent Mechanisms
  
• Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation
  
• Combination Therapy for the Treatment of Cancer
  
• Inhibitor of Retroviral Integrases and Tn5 Transposase
  
• Anti-Androgen Treatment of Breast Cancer
  
• A Novel Gene Important in Lymphocyte Development
  
• Modulation of Heavy Metal Homeostasis Reduces Inhibitors of Apoptosis in Human Cells
  
• Peripheral Benzodiazepine Ligand:Drug Conjugates
  
• APPL: A Potential Chemotherapeutic and Cancer Research Tool
  
• Functionalized bs-scFV for Pre-targeted Imaging and Therapy
  
• A System for Prevention of Breast Cancer
  
• Pregnancy-associated Genetic Signature in the Human Breast
  
• Use of Human Chorionic Gonadotropin in the Prevention of Breast Cancer
  
• Mutation in EGFR Predicts Response of Ovarian Cancer Patients to Gefitinib
  
• Creation and Use of Fluorine-labelled Haptens with Bispecific Antibodies for Imaging
  
• Dendroamide Compounds and Their Use in Chemosensitizing Multidrug Resistant Cells
  
• MRP-Related Transporter Genes Involved in Resistance to Cytotoxic Chemotherapeutic Drugs
  

• Markers for Renal Cancer Diagnosis and Prognosis
  
• Markers for Early Diagnosis of Cancer
  
• Method of Identifying Markers for Early Diagnosis of Kidney, Breast, Ovarian and Colon Cancersr
  
• Hypermethylation of the GADD45b Gene as a Marker for Hormone-refractory Prostate Cancer and Aggressiveness
  
• Serum Protein Markers Associed with Response to Cetuximab
  
• Breast Cancer Markers
  
• MDM2 as a Marker for Prostate Cancer
  
• Protein Markers for Colon Cancer
  

• Hexameric Porphobilinogen Synthase: A Novel Target for Antimicrobial, Antifungal, Antiparasitic, and Herbicide Development
  
• Alternate Morpheeins of Allosteric Proteins as a Target for the Development of Bioactive Molecules
  
• Anti MDR Activity of Fungal Agent
  

• ATR Kinase: A Novel Target for Anti-retroviral Drug Discovery
  
• Recombinant Baculoviruses Expressing the RNA-dependent RNA Polymerase of Hepatitis C and of West Nile Virus
  
• A Novel Treatment for Hepatitis B
  
• Inhibition of HIV-1 Replication in Human Peripheral Blood
  
• Use of Secreted-cell Bound Poxvirus a Vaccine
  
• Recombinant Vaccinia Protein Made in Bacteria
  

• High Energy Polyenergetic Ion Selection Systems, Ion Beam Therapy Systems and Ion Beam Treatment Centers
  
• Method of Modulating Laser-accelerated Protons for Radiation Therapy
  
• Laser-accelerated Proton Therapy Units and Superconducting Magnet Systems for Same
  
• Target Design for High-power Laser Accelerated Protons
  
• Shielding for Compact Radiation Sources
  
• Methods and Systems for Increasing the Energy of Positive Ions Accelerated by High-power Lasers
  

• Methods to Induce Liver and Pancreas Cell Differentation
  
• Compositions and Methods for Altering Pancreas or Liver Function
  
• Targeted Method for Gene Therapy: Chimeric Enzyme for Promoting Targeted Integration of Foreign DNA into a Host Genome
  
• Compounds and Methods for Therapeutic Intervention in Preventing Diabetic Complications and Procedures for Assessing Risk of Developing Complications and Determining the Efficacy of Therapeutic Intervention
  

• Surgical Restraint System
  
• Urostomy Pouch Adapter
  
• Novel Respiratory and Surgical Mask
  
• Method and Apparatus for Endoscopic Examination of Lesions
  

• Cell-based Assay to Screen for Inhibitors of Pak
  
• Paktide-8 Amino Acid Peptide as a Substrate for Pak Phosphorylation
  
• ELISA Assay to Detect Ectromelia Virus in Mice
  
• Cultured Cell Line to Express the Hepatitis B Virus Genome
  
• HepB Producing Cell Line
  
• Compositions and Methods for Inducing Apoptosis in BCL2
  
• Transgenic Animal Model for Human Cutaneous Melanoma
  
• Improved Reverse N-Hybrid Screening Method
  
• Expression, Purification, and Characterization of a Bacterial Homolog of S1 Nuclease
  
• Mouse Model for Mantle Cell Lymphomas
  
• AKT2 Knockout Mouse
  
• APPL Knockout Mouse
  
• Model of Spontaneous Mesothelioma
  
• Human HER2/neu Transgenic Mouse
  
• Monoclonal Antibodies to MAD1 and MAD2
  
• Cre Mice for Studying Liver and Gut Progenitor Cells
  
• Antibodies to FoxA1
  
• Antibodies to GATA-4
  
• Cell Culture and Animal Model for Hepatitis C Virus
  
• SV40 Transgenic Mouse Model of Ovarian Cancer
  
• Ovarian Cancer Rat Model and Cell Line
  
• Lymphoblast Cell Lines Derived from TSC Patients with Known Mutations